MACUGEN

LOE Approaching

pegaptanib sodium

NDAINTRAVITREALINJECTABLEPriority Review
Approved
Sep 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Clinical Trials (5)

NCT01175070Phase 4Completed

Intravitreal Macugen for Ischaemic Diabetic Macular Oedema

Started Jan 2011
30 enrolled
Diabetic Macular Oedema
NCT01189461Phase 3Completed

Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema

Started Jan 2011
46 enrolled
Anti- VGF InhibitorDiabetic Macular EdemaDiabetic Retinopathy
NCT01100307Phase 3Completed

A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema

Started May 2010
243 enrolled
Macular EdemaDiabetic MellitusRetinal Disease
NCT01573572Phase 4Completed

Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium

Started Apr 2010
131 enrolled
Age-Related Macular DegenerationRetinal Vein OcclusionDiabetic Macular Edema
NCT00787319N/ACompleted

Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice

Started Jan 2010
108 enrolled
Age-related Macular Degeneration